1. Gender as a Risk Factor for Adverse Events to Medications

   • Judith C. Kando
   • Kimberly A. Yonkers
   • Jonathan O. Cole

   Leading Article 03 November 2012 Pages: 1 - 6

2. Antiplatelet Drugs

   • Karsten Schrör

   Review Article 03 November 2012 Pages: 7 - 28

3. Thrombolytic Agents in Development

   • Marc Verstraete
   • Henri R. Lijnen
   • Desiré Collen

   Review Article 03 November 2012 Pages: 29 - 42

4. Guidelines for the Use of Zidovudine in Pregnant Women with HIV Infection

   • Marco De Santis
   • Giuseppe Noia
   • Salvatore Mancuso

   Practical Therapeutics 03 November 2012 Pages: 43 - 47

5. Skin Cancer

   • Ronald Marks
   • Richard J. Motley

   Practical Therapeutics 03 November 2012 Pages: 48 - 61

6. A Guide to the Treatment of Lower Respiratory Tract Infections

   • Friedrich Vogel

   Practical Therapeutics 03 November 2012 Pages: 62 - 72

7. Meropenem

   • Lynda R. Wiseman
   • Antona J. Wagstaff
   • Harriet M. Bryson

   Drug Evaluation 03 November 2012 Pages: 73 - 101

8. Alteplase

   • Jane C. Gillis
   • Antona J. Wagstaff
   • Karen L. Goa

   Drug Evaluation 03 November 2012 Pages: 102 - 136

9. Sulfasalazine

   • Christopher P. Rains
   • Stuart Noble
   • Diana Faulds

   Drug Evaluation 03 November 2012 Pages: 137 - 156

10. Erratum to Tianeptine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression

    • M. I. Wilde
    • P. Benfield

    Erratum 03 November 2012 Pages: 156 - 156

11. Transnasal Butorphanol

    • Jane C. Gillis
    • Paul Benfield
    • Karen L. Goa

    Drug Evaluation 03 November 2012 Pages: 157 - 175

12. Atovaquone

    • Caroline M. Spencer
    • Karen L. Goa

    Drug Evaluation 03 November 2012 Pages: 176 - 196